Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oncotarget|March 24, 2016
A phase I study of indoximod in patients with advanced malignanciesHatem H Soliman, Susan E Minton, Hyo Sook Han, et al.
Biological Research for Nursing|May 2, 2022
Translational Genomic Research: The Association between Genetic Profiles and Cognitive Functioning or Cardiac Function Among Breast Cancer Survivors Completing ChemotherapyJong Y Park, Cecile A Lengacher, Richard R Reich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2018
Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant TrialAditya Bardia, Marina Parton, Sherko Kümmel, et al.
Scientific Reports|November 27, 2019
Expression of the BAD pathway is a marker of triple-negative status and poor outcomeBernadette M Boac, Forough Abbasi, Roohi Ismail-Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 StudyPatrick Neven, Nicole Stahl, Maria Vidal, et al.
Journal of the National Cancer Institute|November 12, 2020
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging CouncilsLauren A Baldassarre, Eric H Yang, Richard K Cheng, et al.
Gynecologic Oncology|October 23, 2024
Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer: Results from the phase 1a/1b EMBER studyKan Yonemori, Valentina Boni, Kim Gun Min, et al.
Journal of the American College of Cardiology|December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
Cancer Research|December 9, 2024
Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast CancerShripad V Bhagwat, Cecilia Mur, Matthew Vandekopple, et al.
Pageof 5